1 March 2024 false No description of principal activity Taxfiler 2024.6 3098083business:PrivateLimitedCompanyLtd2024-03-012025-02-28 30980832024-02-29 30980832024-03-012025-02-28 3098083business:AuditExemptWithAccountantsReport2024-03-012025-02-28 3098083business:FilletedAccounts2024-03-012025-02-28 30980832025-02-28 3098083business:Director12024-03-012025-02-28 3098083business:RegisteredOffice2024-03-012025-02-28 30980832024-02-29 3098083core:WithinOneYear2025-02-28 3098083core:WithinOneYear2024-02-29 3098083core:ShareCapitalcore:PreviouslyStatedAmount2025-02-28 3098083core:ShareCapitalcore:PreviouslyStatedAmount2024-02-29 3098083core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-02-28 3098083core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-02-29 3098083core:PreviouslyStatedAmount2025-02-28 3098083core:PreviouslyStatedAmount2024-02-29 3098083business:SmallEntities2024-03-012025-02-28 3098083countries:EnglandWales2024-03-012025-02-28 3098083core:PlantMachinery2024-03-012025-02-28 3098083core:MotorVehicles2024-03-012025-02-28 3098083core:LandBuildings2024-02-29 3098083core:PlantMachinery2024-02-29 3098083core:FurnitureFittings2024-02-29 3098083core:LandBuildings2025-02-28 3098083core:PlantMachinery2025-02-28 3098083core:FurnitureFittings2025-02-28 3098083core:LandBuildings2024-03-012025-02-28 3098083core:FurnitureFittings2024-03-012025-02-28 30980832023-03-012024-02-29 iso4217:GBP xbrli:pure
Company Registration No. 3098083 (England and Wales)
Phyto Therapeutics Limited Unaudited accounts for the year ended 28 February 2025
Phyto Therapeutics Limited Unaudited accounts Contents
Page
- 2 -
Phyto Therapeutics Limited Company Information for the year ended 28 February 2025
Director
K R Cavan
Company Number
3098083 (England and Wales)
Registered Office
337 Baslow Road Totley SHEFFIELD S17 4AD
Accountants
HART SIMPSON 65 Ward Street New Tupton Chesterfield Derbyshire S42 6XR
- 3 -
Phyto Therapeutics Limited Statement of financial position as at 28 February 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
1,019,947 
1,022,592 
Current assets
Debtors
103,366 
103,366 
Cash at bank and in hand
1,318 
12,220 
104,684 
115,586 
Creditors: amounts falling due within one year
(73,680)
(71,410)
Net current assets
31,004 
44,176 
Net assets
1,050,951 
1,066,768 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
1,050,851 
1,066,668 
Shareholders' funds
1,050,951 
1,066,768 
For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 19 March 2025 and were signed on its behalf by
K R Cavan Director Company Registration No. 3098083
- 4 -
Phyto Therapeutics Limited Notes to the Accounts for the year ended 28 February 2025
1
Statutory information
Phyto Therapeutics Limited is a private company, limited by shares, registered in England and Wales, registration number 3098083. The registered office is 337 Baslow Road, Totley, SHEFFIELD, S17 4AD.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
5%
Motor vehicles
5%
4
Tangible fixed assets
Land & buildings 
Plant & machinery 
Fixtures & fittings 
Total 
£ 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At cost 
At 1 March 2024
1,004,959 
118,778 
40,167 
1,163,904 
At 28 February 2025
1,004,959 
118,778 
40,167 
1,163,904 
Depreciation
At 1 March 2024
- 
106,080 
35,232 
141,312 
Charge for the year
- 
1,905 
740 
2,645 
At 28 February 2025
- 
107,985 
35,972 
143,957 
Net book value
At 28 February 2025
1,004,959 
10,793 
4,195 
1,019,947 
At 29 February 2024
1,004,959 
12,698 
4,935 
1,022,592 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Other debtors
103,366 
103,366 
- 5 -
Phyto Therapeutics Limited Notes to the Accounts for the year ended 28 February 2025
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
VAT
(5,543)
(2,953)
Trade creditors
750 
750 
Taxes and social security
2,009 
1,949 
Other creditors
31,750 
26,750 
Loans from directors
44,714 
44,914 
73,680 
71,410 
7
Transactions with related parties
At the balance sheet date, an amount of £44714 (2024 - £44914)was owed to the company the company to Ms K R Cavan, the Director. The loan was interest free and no repayment terms have been agreed at the balance sheet date. At the balance sheet date, an amount of £7793.00 (2024 £7793) was owed to the company by Dore Trading Ltd, a company of which Ms K R Cavan, is also a Director. The loan was interest free and no repayment terms have been agreed at the balance sheet date. At the balance sheet date, an amount of £90572 (2024 £90572) was owed to the company by True Brit London Ltd, a company of which Ms K R Cavan, is also a Director. The loan was interest free and no repayment terms have been agreed at the balance sheet date. At the balance sheet date, an amount of £5000 (2024 £5000) was owed to the company by Kaytico Ltd, a company of which Ms K R Cavan, is also a Director. The loan was interest free and no repayment terms have been agreed at the balance sheet date. At the balance sheet date, an amount of £21750 (2024 £26750) was owed by the company to ICD Laboratories Ltd, a company of which Ms K R Cavan, is also a Director. The loan was interest free and no repayment terms have been agreed at the balance sheet date.
8
Average number of employees
During the year the average number of employees was 0 (2024: 7).
- 6 -